Afya (NASDAQ:AFYA) Upgraded by Wall Street Zen to “Strong-Buy” Rating

Afya (NASDAQ:AFYA) was upgraded by stock analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued on Saturday.

Several other brokerages have also recently commented on AFYA. UBS Group reduced their price objective on shares of Afya from $19.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and set a $22.00 price target (down previously from $24.50) on shares of Afya in a research note on Wednesday. Two equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $17.88.

Afya Price Performance

Shares of NASDAQ AFYA opened at $15.04 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.98 and a current ratio of 0.98. Afya has a one year low of $13.47 and a one year high of $19.90. The firm has a market capitalization of $1.41 billion, a P/E ratio of 10.82, a PEG ratio of 0.49 and a beta of 0.53. The company’s fifty day moving average is $14.74 and its two-hundred day moving average is $15.14.

Institutional Trading of Afya

Several large investors have recently modified their holdings of AFYA. Goldman Sachs Group Inc. increased its stake in shares of Afya by 167.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after purchasing an additional 28,226 shares in the last quarter. Swedbank AB acquired a new stake in Afya during the 3rd quarter valued at $1,092,000. Dynamic Technology Lab Private Ltd acquired a new stake in Afya during the 2nd quarter valued at $391,000. Carrera Capital Advisors purchased a new position in Afya during the second quarter worth $1,750,000. Finally, Campbell & CO Investment Adviser LLC raised its holdings in shares of Afya by 31.5% in the second quarter. Campbell & CO Investment Adviser LLC now owns 51,340 shares of the company’s stock worth $917,000 after acquiring an additional 12,286 shares during the last quarter. 88.02% of the stock is currently owned by institutional investors and hedge funds.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.